COMPOSITION FOR LIGHTENING AND / OR WHITENING KERATINOUS MATERIALS
An oil-free composition with specific glycols and surfactants enhances the penetration of vitamin B3 derivatives into the stratum corneum, addressing the penetration issues of conventional emulsions and improving lightening/whitening efficacy.
Patent Information
- Application Number
- FR2021001357
- Authority / Receiving Office
- FR · FR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-12-22
- Filing Date
- 2021-02-12
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2041-02-12
AI Technical Summary
Conventional oil-in-water emulsions for skin care and makeup compositions are not satisfactory in terms of lightening and/or whitening due to poor penetration of lightening and/or whitening ingredients like niacinamide into the stratum corneum.
A composition comprising a hydrophilic phase with a glycol having a log P ranging from -0.5 to 4, a surfactant with an HLB value of 8 to 20, and vitamin B3 or its derivatives, formulated as an oil-free liquid, enhances the penetration of these ingredients into keratinous materials.
The composition effectively improves the penetration of vitamin B3 and its derivatives into the stratum corneum, facilitating better lightening and/or whitening effects.
Smart Images

Figure 00000019_0000 
Figure 00000019_0001 
Figure 00000019_0002
Abstract
Description
Title of the invention: COMPOSITION FOR LIGHTENING AND / OR WHITENING KERATINOUS MATERIALS Technical field
[0001] The present invention relates to a composition and a use thereof. In particular, the present invention relates to a composition for lightening and / or bleaching keratinous materials, in particular the skin. The present invention also relates to a non-therapeutic method for lightening and / or bleaching keratinous materials, and to the use of a combination of at least one glycol with a log P ranging from -0.5 to 4 and at least one surfactant with an HLB value of 8 to 20 at a temperature of 25°C to improve the penetration of a lightening and / or bleaching ingredient selected from vitamin B3 and its derivatives into keratinous materials. CONTEXT OF ART
[0002] The color of human skin depends on various factors, including the seasons of the year, race, and sex; it is mainly determined by the nature and concentration of melanin produced by melanocytes. Melanocytes are specialized cells that synthesize melanin by means of specific organelles, melanosomes. In addition, at different times in their lives, some individuals experience the appearance of dark and / or colored spots on the skin, particularly on the hands, which gives the skin its heterogeneity.
[0003] For various reasons linked in particular to greater comfort of use (softness, emollience, and the like), current compositions for the care and / or makeup of keratinous materials, in particular of the skin, are generally in the form of an oil-in-water (O / W) type emulsion consisting of a continuous aqueous dispersing phase and a discontinuous oily dispersing phase, or a water-in-oil (W / O) type emulsion consisting of a continuous oily dispersing phase and a discontinuous aqueous dispersing phase.
[0004] O / W emulsions are the most sought after in the field of cosmetics, because they have an aqueous phase as an external phase, which gives them, when applied to the skin, a fresher, less greasy and lighter feel than W / O emulsions.
[0005] However, due to their natural peculiarity, conventional oil-in-water emulsions are not entirely satisfactory, particularly in terms of lightening and / or whitening the skin.
[0006] Efforts have been made to introduce lightening and / or whitening ingredients- such as niacinamide or its derivative in cosmetic products. However, for many products intended to lighten and / or whiten the skin, it is difficult for the lightening and / or whitening ingredients contained to penetrate the skin.
[0007] For compositions containing lightening and / or whitening ingredients, the penetration of the active ingredients into the stratum corneum is one of the most important properties.
[0008] It is therefore always necessary to formulate a composition for lightening and / or whitening the skin, which has an improved effect in terms of penetration of the lightening and / or whitening ingredient such as niacinamide or its derivative contained in the stratum corneum. Summary of the invention
[0009] The inventors have now discovered that it is possible to formulate such compositions having an improved effect in terms of penetration of the cosmetic active ingredient such as niacinamide or its derivative contained in the stratum corneum.
[0010] Thus, firstly, the present invention provides a composition for lightening and / or bleaching keratinous materials, comprising in a hydrophilic phase:
[0011] (i) at least one glycol whose log P ranges from -0.5 to 4;
[0012] (ii) at least one surfactant having an HLB value of 8 to 20 at the temperature of 25°C; and
[0013] (iii) at least one lightening and / or whitening ingredient chosen from vitamin B3 and its derivatives,
[0014] wherein the composition is oil-free.
[0015] The composition of the present invention may be in the form of a liquid, for example, a tonic lotion or a serum.
[0016] In a second aspect, the present invention provides a non-therapeutic method for lightening and / or bleaching keratinous materials, comprising applying the composition according to the first aspect of the present invention to the keratinous materials.
[0017] It has been found that vitamin B3 and / or its derivative contained in the composition according to the present invention can easily penetrate into the stratum corneum.
[0018] In a third aspect, the present invention provides the use of a combination of at least one glycol with a log P ranging from -0.5 to 4 and at least one surfactant with an HLB value of 8 to 20 at a temperature of 25°C to improve the penetration of a lightening and / or whitening ingredient chosen from vitamin B3 and its derivatives into keratinous materials.
[0019] Other subjects and features, aspects and advantages of the present invention will become more apparent from the detailed description and examples which follow. Brief Description of the Drawings
[0020] Implementations of the present invention will be described, by way of example only, with reference to the accompanying figures, in which
[0021] [Fig. 1] [Fig. 1] shows the penetration profile of niacinamide for the compositions of the invention formulas 1 and 2 and of the comparative formula 1.
[0022] [Fig.2] [Fig.2] shows the penetration profile of niacinamide for the compositions of the invention formulas 3 and 4 and of the comparative formula 1.
[0023] [Fig.3] [Fig.3] shows the penetration profile of niacinamide for the compositions of the invention formulas 5 and 6 and of the comparative formula 1. DETAILED DESCRIPTION OF THE INVENTION
[0024] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which the present invention pertains. Where the definition of a term in this specification conflicts with the meaning commonly understood by those skilled in the art to which the present invention pertains, the definition described in this specification applies.
[0025] In the following and unless otherwise indicated, the limits of a range of values are included in this range, in particular in the expressions "between ... and..." and "ranging from ... to ...".
[0026] Furthermore, the expression "at least one" used in the present description is equivalent to the expression "one or more".
[0027] In the present application, the term "comprising" should be interpreted to encompass all the specifically mentioned features as well as optional, additional and unspecified features. As used in the present application, the term "comprising" also discloses the embodiment in which no features other than those specifically mentioned are present (i.e., "consisting of").
[0028] All percentages in the present invention refer to percentages by weight, unless otherwise indicated.
[0029] For the purposes of the present invention, the term "keratinous materials" is intended to cover human skin, mucous membranes such as the lips. Facial skin is more particularly considered according to the present invention.
[0030] By "oil-free" is meant that no oil is intentionally added and that the oil content of the composition is less than 0.5% by weight, relative to the total weight of the composition. In particular, there is no oil in the composition.
[0031] According to the first aspect, the present invention provides a composition for lightening and / or bleaching keratinous materials, comprising in a hydrophilic phase:
[0032] (i) at least one glycol whose log P ranges from -0.5 to 4;
[0033] (ii) at least one surfactant having an HLB value of 8 to 20 at the temperature of 25°C; and
[0034] (iii) at least one lightening and / or whitening ingredient chosen from vitamin B 3 and its derivatives;
[0035] wherein the composition is oil-free. Hydrophilic phase
[0036] According to the first aspect, the composition of the present invention comprises a hydrophilic phase.
[0037] The hydrophilic phase comprises water.
[0038] Preferably, the hydrophilic phase comprises at least one organic solvent miscible with water (at room temperature 25°C) such as, for example, monoalcohols having from 2 to 6 carbon atoms such as ethanol, isopropanol, triols such as glycerin.
[0039] Advantageously, water is present in the composition of the present invention in an amount ranging from 60 to 90% by weight, relative to the total weight of the composition. Glycol
[0040] According to the first aspect, the composition of the present invention comprises at least one glycol whose log P ranges from -0.5 to 4.
[0041] A log P value is a value for the decimal logarithm of the apparent octan-l-ol / water partition coefficient. Log p values are known and are determined by a standard test that determines the concentration of glycol in octan-l-ol and water. Log P can be calculated according to the method described in the article by Meylan and Howard: Atom / Fragment contribution method for estimating octanol-water partition coefficients, J. Pharm. Sci. 84:83-92, 1995. This value can also be calculated using many commercially available software programs that determine log P based on the structure of a molecule. An example is the U.S. Environmental Protection Agency's Epiwin software.
[0042] The values can be calculated in particular using the ACD (Advanced Chemistry Development) Solaris V4.67 software; they can also be obtained from Exploring QSAR: hydrophobicity, electronic and steric constants (ACS professional reference book, 1995).
[0043] Preferably, the glycol is chosen from C4-Ci0 glycols.
[0044] More preferably, the glycol is selected from C4-C8 glycols.
[0045] Thus, in certain preferred embodiments, the composition of the present invention comprises at least one C4-C10 glycol, preferably a C4-C8 glycol.
[0046] Examples of C4-Ci0 glycols that may be used in the composition of the present invention include butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol, heptanediol, octanediol, nonanediol, and decylene glycol.
[0047] In the present invention, the definition of glycols includes all possible isomers. For example, pentylene glycol includes 1,5-pentylene glycol, 2,4-pentylene glycol, etc.
[0048] In a more preferred embodiment, the composition comprises a combination of butylene glycol, pentylene glycol and dipropylene glycol.
[0049] The glycol is advantageously present in a range of 2% to 40% by weight, preferably 5% to 30% by weight, more preferably 8% to 20% by weight, relative to the total weight of the composition. Surfactants
[0050] According to the first aspect, the composition of the present invention comprises at least one surfactant having an HLB value of 8 to 20 at a temperature of 25°C.
[0051] The HLB (hydrophilic-lipophilic balance) value is defined according to the method of Griffin in J. Ploughshare. Cosm. Chem. 1954 (volume 5), pages 249 to 256.
[0052] The surfactant advantageously has an HLB value of 10 to 15, preferably 12 to 15, at a temperature of 25°C.
[0053] Preferably, the surfactant is chosen from non-ionic surfactants, anionic surfactants, amphoteric or zwitterionic surfactants, or a mixture thereof.
[0054] The nonionic surfactants suitable for the present composition may be chosen from
[0055] - polyoxyethylenated sorbitol fatty esters such as the product sold under the name TWEEN 20 mination by HERE;
[0056] - polyoxyethylenated fatty alcohols such as the product sold under the name REMCOPAL 21912 AL by Gerland;
[0057] - polyoxyethylenated alkylphenols such as the product sold under the name TRITON X 100 by Rôhm-Haas; And
[0058] - ethylene oxide and propylene oxide condensates such as those sold under the names SYNPERONIC PE by ICI and in particular those referenced L 31, L 64, F 38, F 88, L 92, P 103, F 108 and F 127;
[0059] - esters of fatty acids and glycerol or polyglycerol, preferably esters of C6-C30 fatty acids, more preferably C8-C16, saturated or unsaturated, and glycerol or polyglycerol. Examples include glyceryl stearate, glyceryl isostearate, polyglyceryl-3 diisostearate, glyceryl caprylate, polyglyceryl-4 caprate, polyglyceryl-10 laurate, or a mixture thereof. Such products are commercially available, for example, a mixture of glyceryl stearate and PEG-100 stearate sold under the brand name Simulsol™ 165 sold by Seppic, or the polyglyceryl-4 caprate product sold under the brand name Tegosoft® PC 41 by Evonik Goldshmidt.
[0060] - ethers of polyethylene glycol and / or polypropylene glycol, and glycerol such as that glyceride-26 and PPG-24 glycerieth-24;
[0061] - esters derived from the reaction of a) fatty acids and b) polyethylene ethers glycol and / or polypropylene glycol glycerol such as, for example, glycereth-7, or glycereth-25 isostearate of PCA;
[0062] - esters of sucrose and fatty acids containing from 12 to 30 carbon atoms, in particular 14 to 20 carbon atoms, said esters possibly comprising 2 to 5 fatty chains, such as for example sucrose distearate, sucrose tristearate and sucrose palmitate;
[0063] - alkylpolyglucosides, preferably those which contain an alkyl group having from 6 to 30 carbon atoms and preferably from 8 to 16 carbon atoms, and which contain a hydrophilic group (glucoside) preferably comprising 1.2 to 3 sugar units. Examples include decyl glucoside (alkyl-Cç / Cn -polyglucoside (1.4)) such as the product sold under the name Plantacare® 2000 UP by Cognis (BASF), the products sold under the name MYDOL 10® by Kao Chemicals, the product sold under the name PLANTAREN® 2000 UP by Cognis, and the product sold under the name ORAMIX® NS 10 by Seppic; caprylyl / capryl glucoside such as the product sold under the name ORAMIX® CG 110 by Seppic; laurylglucoside such as products sold under the names PLANTAREN® 1200 N and PLANTACARE® 1200 by Cognis;and cocoglucoside such as the product sold under the name PLANTACARE® 818 / UP by Cognis, cetostearylglucoside optionally in a mixture with cetostearyl alcohol sold, for example, under the name MONTANOV 68 by Seppic under the name TEGO® CARE CG90 by Goldschmidt and under the name EMULGADE KE3302 by Henkel; arachidylglucoside, for example in the form of a mixture of arachidic and behenyl alcohols and arachidylglucoside sold under the name MONTANOV 202 by Seppic; cocoylethylglucoside, for example in the form of a mixture (35 / 65) with cetyl and stearyl alcohols, sold under the name MONTANOV 82 by Seppic and mixtures thereof. ;
[0064] Among the anionic surfactants, we can cite in particular:
[0065] - alkyl sulfates, alkyl ether sulfates and their salts, in particular their salts of sodium, such as sodium laureth sulfate / sodium laureth sulfate mixture magnesium / sodium laureth-8 sulfate / magnesium laureth-8 sulfate sold under the name TEXAPON ASV by Henkel; sodium lauryl ether sulfate (C^ u 70 / 30) (2.2 EO), sold under the names SIPON AOS 225 or TEXAPON® N702 PASTE by Henkel; ammonium lauryl ether sulfate (C^.u 70 / 30) (3 EO) sold under the name SIPON LEA 370 by Henkel; alkyl (C12-C14) ether (9 EO) ammonium sulfate, sold under the name RHODAPEX® AB / 20 by Rhodia Chimie;
[0066] - alkylsulphoacetates, such as those sold under the name LATHANOL® LAL by Stepan;
[0067] - alkylsulfosuccinates, for example lauric alcohol monosulfosuccinate (in C 12 / C14 70 / 30) oxyethylenated (3 EO) sold under the names SETACIN 103 SPECIAL or REWOPOL SB-FA 30 K 4 by Witco, the disodium salt of a hemisulfosuccinate of C12-C14 alcohols sold under the name SETACIN F SPECIAL PASTE by Zschimmer Schwarz, oxyethylenated disodium oleamidosulfosuccinate (2 EO) sold under the name STANDAPOL SH 135 by Henkel, oxyethylenated lauramide monosulfosuccinate (5 EO) sold under the name LEBON A-5000 by Sanyo, the disodium salt of oxyethylenated lauryl citrate monosulfosuccinate (10 EO) sold under the name REWOPOL® SB CS 50 by Witco or the disodium salt of monoethanolamide monosulfosuccinate acid ricinoleic sold under the name REWODERM® S 1333 by Witco;
[0068] - polypeptides which are obtained, for example, by condensation of a chain fatty with cereal amino acids and in particular wheat and oat amino acids, such as, for example, the potassium salt of lauroyl hydrolyzed wheat protein sold under the name AMINOFOAM™ W OR by Croda, the triethanolamine salt of cocoyl hydrolyzed soy protein sold under the name MAY-TEIN SY by Maybrook, the sodium salt of lauroyl oat amino acids sold under the name PROTEOL™ O AT by Seppic, the hydrolyzate of collagen grafted onto coconut fatty acid sold under the name GELIDERM 3000 by Deutsche Gélatine or the soy proteins acylated with hydrogenated coconut acids sold under the name PROTEOL VS 22 by Seppic;
[0069] - amino acid derivatives, for example amino acid salts, for example among sarcosinates and in particular acylsarcosinates, such as sodium lauroyl sarcosinate, sold under the name SARKOSYL NL 97 by Ciba or sold under the name ORAMIX™ L 30 by Seppic, sodium myristoyl sarcosinate, sold under the name NIKKOL SARCOSINATE MN by Nikkol, or sodium palmitoyl sarcosinate, sold under the name NIKKOL SARCOSINATE PN by Nikkol; alaninates, such as sodium N-lauroyl-N-methylamidopropionate, sold under the name SODIUM NIKKOL ALANINATE LN 30 by Nikkol or sold under the name ALANONE ALE by Kawaken, and triethanolamine N-lauroyl-N-methylalanine, sold under the name ALANONE ALTA by Kawaken; N-acylglutamates, such as triethanolamine monococoyl glutamate, sold under the name ACYLGLUTAMATE CT-12 by Ajinomoto, and triethanolamine lauroyl glutamate, sold under the name ACYLGLUTAMATE LT-12 by Ajinomoto; aspartates, such as the mixture of triethanolamine N-lauroyl aspartate and triethanolamine N-myristoyl aspartate, sold under the name ASPARACK LM-TS2 by Mitsubishi; or glycine derivatives, such as sodium N-cocoyl glycinate and potassium N-cocoyl glycinate, for example, the products sold under the names AMILITE GCS-12 and AMILITE GCK-12 by Ajinomoto; lysinates, such as sodium dilauramidoglutamide lysine, for example the product sold under the name PELLICER L-30 by ASAHI KASEI;
[0070] - sulfonates, for example α-olefin sulfonates, such as sulfonate sodium α-olefins (C14-16) sold under the name BIO-TERGE® AS-40 by Stepan, sold under the names WITCONATE AOS PROTÉGÉ and SULFRAMINE AOS PH 12 by Witco or sold under the name BIO-TERGE® AS-40 CG by Stepan or sodium secondary olefin sulfonate sold under the name HOSTAPUR® SAS 30 by Clariant; or linear alkylarylsulfonates, such as sodium xylenesulfonate sold under the names MANROSOL SXS30, MANROSOL SXS40 or MANROSOL SXS93 by Manro;
[0071] - isethionates, in particular acyl isethionates, such as cocoyl isethionate of sodium, for example the product sold under the name JORDAPON CI P by Jordan.
[0072] Among the amphoteric or zwitterionic surfactants, we can mention in particular:
[0073] - alkylamido alkylamine derivatives, such as N- N-disodium cocoyl-N-carboxymethoxyethyl-N-(carboxymethyl)-ethylenediamine (CTFA name: Disodium cocoamphodiacetate), sold in aqueous saline solution under the name MIRANOL C2M CONC NP by Rhodia Chimie; N-sodium N-cocoyl-N-hydroxyethyl-N-(carboxymethyl)ethylenediamine (CTFA name: sodium cocoamphoacetate) and the mixture of coconut acid ethanolamides (CTFA name: Cocamide DEA);
[0074] - betaines, such as coco betaine, such as the product sold under the name DEHYTON® AB-30 by Henkel, lauryl betaine, such as the product sold under the name GENAGEN® KB by Clariant, and the product sold under the name EMPIGEN BB / LS by INNOSPEC ACTIVE CHEMICALS, oxyethylenated lauryl betaine (10 EO), such as the product sold under the name LAURYL ETHER (10 EO) BETAINE by Shin Nihon Rica, or oxyethylenated stearyl betaine (10 EO), such as the product sold under the name STEARYL ETHER (10 EO) BETAINE by Shin Nihon Rica;
[0075] - alkyl amidopropyl betaines and their derivatives, such as cocami- dopropyl betaine, sold under the name LEBON 2000 HG by Sanyo or sold under the name EMPIGEN® BB by Albright & Wilson, lauramidopropyl betaine, sold under the name REWOTERIC AMB12P® by Witco, such as cocamidopropyl betaine, for example products sold under the names TEGO BETAINE by Goldschmidt;
[0076] - imidazoline derivatives, such as the product sold under the name of CHIMEXANE HD by Chimex; and
[0077] - their mixtures.
[0078] Preferably, the surfactant is chosen from esters of fatty acids and glycerol or polyglycerol, amino acid salts, betaines and a mixture thereof.
[0079] More preferably, the surfactant is chosen from esters of C6-C30, preferably C8-C16, saturated or unsaturated fatty acids and glycerol or polyglycerol, lysinates, betaines, and a mixture thereof.
[0080] According to a preferred embodiment, the surfactant is chosen from sodium dilau-ramidoglutamide lysine, polyglyceryl-4 caprate, polyglyceryl-10 laurate, laurylbetaine and a mixture thereof.
[0081] The surfactant is advantageously present in a range of 0.001% to 3% by weight, preferably 0.003% to 2% by weight, more preferably 0.005% to 1% by weight, relative to the total weight of the composition. Vitamin B3 and its derivatives
[0082] According to the first aspect, the composition of the present invention comprises at least one lightening and / or whitening ingredient chosen from vitamin B3 and its derivatives.
[0083] Niacinamide is also called vitamin B3 and vitamin PP, and has the following structure:
[0084] n
[0085] Vitamin B3 derivatives that may be mentioned include, for example, nicotinic acid esters such as tocopherol nicotinate, amides derived from niacinamide by substitution of the hydrogen groups of -CONH2, reaction products with carboxylic acids and amino acids, esters of nicotinyl alcohol and carboxylic acids such as acetic acid, salicylic acid, glycolic acid or palmitic acid.
[0086] The following derivatives may also be mentioned: 2-chloronicotinamide, 6-methylnicotinamide, 6-aminonicotinamide, N-methylnicotinamide, N,N-dimethylnicotinamide, N-(hydroxymethyl)nicotinamide, quinoline acid imide, nicotinanilide, N-benzylnicotinamide, N-ethylnicotinamide, nifenazone, nicotinaldehyde, isonicotinic acid, methylisonicotinic acid, thionicotinamide, nialamide, 2-mercaptonicotinic acid, nicomol and niaprazine, methyl nicotinate and sodium nicotinate.
[0087] Other derivatives of vitamin B3 which may also be mentioned include its inorganic salts, such as chlorides, bromides, iodides or carbonates, and its organic salts, such as salts obtained by reaction with carboxylic acids, such as acetate, salicylate, glycolate, lactate, malate, citrate, mandelate, tartrate, etc.
[0088] The lightening and / or whitening ingredient chosen from vitamin B3 and its derivatives is advantageously present in a range of 0.1% to 15% by weight, preferably 0.5% to 10% by weight, more preferably 1% to 8% by weight, relative to the total weight of the composition. Additional cosmetic active ingredients
[0089] Depending on the final objective, the composition according to the present invention may comprise one or more additional cosmetic active ingredients.
[0090] As cosmetic active ingredients which can be used in the composition of the present invention, mention may be made, for example, of enzymes, flavonoids, moisturizing agents, anti-inflammatory agents, peeling agents, anti-aging agents, antioxidants, depigmenting agents, α-hydroxy acids, tightening agents and mixtures thereof.
[0091] It is easy for a person skilled in the art to adjust the amount of the additional cosmetic active ingredient depending on the final use of the composition according to the present invention. Additional adjuvants or additives
[0092] The composition of the present invention may comprise conventional cosmetic adjuvants or additives, for example, perfumes, chelating agents (e.g., disodium EDTA), preservatives (e.g., hydroxyacetophenone, chlorphenesin, and phenoxyethanol) and bactericides, thickeners, fillers, pH regulators (e.g., citric acid, sodium hydroxide, potassium hydroxide), and mixtures thereof.
[0093] A person skilled in the art can choose the amount of additional adjuvants or additives so as not to harm the final use of the composition according to the present invention.
[0094] According to a particularly preferred embodiment, the present invention provides a composition for lightening and / or bleaching keratinous materials, comprising a hydrophilic phase, relative to the total weight of the composition:
[0095] (i) from 8% to 20% by weight of a combination of butylene glycol, pentylene glycol and dipropylene glycol;
[0096] (ii) from 0.005% to 1% by weight of at least one surfactant selected from sodium di-lauramidoglutamide lysine, polyglyceryl-4 caprate, polyglyceryl-10 laurate, lauryl betaine and a mixture thereof; and
[0097] (iii) from 1% to 8% by weight of vitamin B3,
[0098] wherein the composition is oil-free. Dosage form
[0099] The composition of the present invention is preferably in liquid form.
[0100] Preferably, the composition according to the present invention has a low viscosity.
[0101] According to a preferred embodiment, the composition of the present invention has a viscosity of less than 50 UD (deviation units), measured at 25°C using a Rheomat 180 viscosimeter equipped with an Ml spindle rotating at 200 rpm. Method and use
[0102] According to the second aspect, the present invention provides a non-therapeutic method for lightening and / or bleaching keratinous materials, comprising applying the composition according to the first aspect of the present invention to the keratinous materials.
[0103] In particular, the keratinous material is intended to designate the skin, in particular the face.
[0104] According to the third aspect, the present invention provides the use of a combination of at least one glycol with a log P ranging from -0.5 to 4 and at least one surfactant with an HLB of 10 to 20 to improve the penetration of a lightening and / or whitening ingredient chosen from vitamin B3 and its derivatives into keratinous materials.
[0105] Glycol with a log P ranging from -0.5 to 4 and surfactant with an HLB value of 8 to 20 at the temperature of 25°C are defined as above.
[0106] Preferably, the at least one glycol is chosen from C4-C10 glycols, and the at least one surfactant is chosen from C6-C30 saturated or unsaturated fatty acid esters and glycerol or polyglycerol, lysinates, betaines, and a mixture thereof.
[0107] More preferably, the at least one glycol is a combination of butylene glycol, pentylene glycol and dipropylene glycol, and the at least one surfactant is selected from sodium dilauramidoglutamide lysine, polyglyceryl-4 caprate, polyglyceryl-10 laurate, lauryl betaine, and a mixture thereof.
[0108] The following examples serve to illustrate the present invention without being limiting. EXAMPLES
[0109] The main raw materials used, trade names and their suppliers are listed in Table 1.
[0110] [Tables 1] INCI name Trade name Supplier HLB BUTYLENE GLYCOL 1,3 BUTYLENE GLYCOL ALZO - PENTYLENE GLYCOL A-LEEN 5 MINASOLVE - DIPROPYLENE GLYCOL DIPROPYLENEGLYC OL CARE BASF - NIACINAMIDE NIACINAMIDE PC DSM NU- TRITIONAL PRODUCTS - HYDROXYACETOPHENONE SymSave® H SYMRISE POLYGLYCERYL-10 LAURATE dermofeel®G 10 L DR STRAETMANS (EVONIK) 15 SODIUM DILAURAMIDO- GLUTAMIDE LYSINE Pellicer ™ L-30 ASAHI KASEI 12.6 LAURYL BETAINE EMPIGEN® BB / LS INNOSPEC ACTIVE CHEMICALS 15 POLYSORBATE 20 TEGO SML 20 MB EVONIK GOLDSCHMIDT 18.6 POLYGLYCERYL-2 OLEATE SUNSOFT Q- 17D(G)-C TAIYO KAGAKU 8 OCTYLDODECYL XYLOSIDE FLUIDANOV 20 Example 1: Preparation of compositions
[0111] The compositions according to comparative formulas (Comp.) 1 and 2 and inventive formulas (Inv.) 1 to 6 were prepared according to the contents given in tables 2 and 3 (the contents are expressed as percentages by weight of active material relative to to the total weight of each composition, unless otherwise indicated).
[0112] [T ableaux2] Ingredients Inv.l Inv.2 Inv.3 Inv.4 Comp. 1% by weight BUTYLENE GLYCOL 7 7 7 7 4.5 PENTYLENE GLYCOL 3 3 3 3 3.5 DIPROPYLENE GLYCOL 3 3 3 3 0 NIACINAMIDE 5 5 5 5 5 WATER QS100 QS100 QS100 QS100 QS100 HYDROXYACETOPHENO NE 0.5 0.5 0.5 0.5 - POLYGLYCERYL-10 LAURATE 0.005 1 - - - DILAURAML LYSINE SODIUM GLUTAMIDE - - 0.5 - - LAURYL BETAINE - - - 0.01 -
[0113] The composition of comparative formula 1 does not include a surfactant having an HLB value of 8 to 20 at a temperature of 25°C.
[0114] [T ableaux3 ] Ingredients Inv.5 Inv.6 Comp.2% by weight PENTYLENE GLYCOL 3 3 3 NIACINAMIDE 5 5 5 WATER QS100 QS100 QS100 HYDROXYACETOPHENO NE 0.5 0.5 0.5 POLYSORBATE 20 0.5 - - POLY-GLYCERYL-2 OLEATE - 0.5 - OCTYLDODECYL XYLOSIDE - - 0.5
[0115] The composition of comparative formula 2 comprises a surfactant with an HLB value of 7.3 rather than a surfactant with an HLB value of 8 to 20 at the temperature of 25 °C. The resulting composition is not stable and separated into two phases, it cannot form a uniform liquid. Preparation process:
[0116] The compositions listed above were prepared as follows, taking as an example the composition of the invention formula 1:
[0117] 1). dissolution of niacinamide in water with stirring to obtain a phase main;
[0118] 2). dissolution of the hydroxyacetophenone in the glycol(s) with stirring until obtaining a clear phase;
[0119] 3). addition of the clear phase comprising the hydroxyacetophenone and the glycol(s) in the main phase with stirring until a clear mixture is obtained;
[0120] 3). Adding the surfactant to the clear mixture with careful stirring to get the composition. Example 2: Evaluation of compositions
[0121] The penetration of niacinamide in each composition prepared in Example 1 was characterized by an in vitro skin permeation test (Strat-M test) using Strat-M, which is a synthetic membrane mimicking the lipophilic component of the stratum corneum available from Merk.
[0122] The procedure was as follows:
[0123] - subjecting a receiving liquid (RF, a PBS solution of pH7.4) to an ul- bath trasonic for 15 minutes to eliminate gas;
[0124] - installation of 3 Franz cells in parallel for each composition on a plateau ;
[0125] - connection of the cells in parallel with a fluidic thermostat in order to to homogenize the temperature for each cell, in which Tbath = 34 °C and T cens = 32 °C;
[0126] - introduction of a magnetic bar into the cells (RF compartment);
[0127] - marking a line on the sampling orifice leaving approximately 1 cm of the inlet of the sampling port to the line, which is a reference for filling the receiver fluid;
[0128] - introduce Molykote 111 (a valve lubricant and sealant) Dow Corning company in a 5 ml plastic syringe, spread the Molykote 111 with the syringe on the sandblasted surface of the receiving part of the cell, place the donor compartment on the Franz cell and make a complete 360° rotation, check that the Molykote 111 is evenly applied to the edges of the Franz cells, removing the donor compartment from the cell and removing excess Molykote inside the cell (donor and recipient compartments) with a cotton swab to avoid contamination;
[0129] - placement of Strat-M membranes in the center of the cells with the shiny side facing the donor compartment without touching the edges of the membrane;
[0130] - alignment of the donor compartment and closure of the Franz cell with a clip without force;
[0131] - introduction of the receiving liquid through the sampling orifice and starting of the agitator at 600 rpm;
[0132] - turning the diffusion cell over and using a stirring bar to eliminate bubbles under the membrane;
[0133] - sampling of 45 mg of the tested composition and application of the composition tested uniformly on the membrane by a 360 degree rotating movement and careful tapping, precisely determining the amount of composition that has been applied to the membrane;
[0134] - collection of 200pL of receiving liquid using a Hamilton syringe of 250pL, at least 3 samples per hour from 1 hour to 24 hours,
[0135] - slowly filling the sampling orifice up to the mark with liquid fresh receiver; and
[0136] - measurement of the quantity of active ingredient in the receiving fluid to determine the relationship between the amount of active ingredient and the penetration time.
[0137] [Fig. 1] shows the penetration profile of niacinamide for the compositions of the invention formulas 1 and 2 and of the comparative formula 1.
[0138] [Fig.2] shows the penetration profile of niacinamide for the compositions of the invention formulas 3 and 4 and of the comparative formula 1.
[0139] [Fig.3] shows the penetration profile of niacinamide for the compositions of the invention formulas 5 and 6 and of the comparative formula 1.
[0140] It can be seen from Figures 1 to 3 that a combination of at least one glycol and at least one surfactant having an HLB value of 8 to 20 at the temperature of 25°C can improve the penetration of niacinamide into the skin after topical application.
[0141] The viscosity of each composition prepared in Example 1 was measured at 25°C using a Rheomat 180 viscometer from ProRheo equipped with an M1 or M3 spindle capable of rotating at 200 rpm.
[0142] The results are summarized in Table 4.
[0143] [Tables4] Inv.l Inv.2 Inv.3 Inv.4 Inv.5 Inv. 6 Comp. 1 Comp.2 Viscosity (UD) 34 (Ml) 34 (Ml) 34 (Ml) 34 (Ml) 34 (Ml) 34 (Ml) 18 (M3) 34 (Ml)
[0144] It can be seen from Table 4 that the compositions according to the present invention have a low viscosity.
Claims
Claims
1. Composition for lightening and / or bleaching keratinous materials, comprising in a hydrophilic phase: (i) from 2% to 40% by weight of a combination of butylene glycol, pentylene glycol and dipropylene glycol; (ii) at least one surfactant having an HLB value of 8 to 20 at a temperature of 25°C; and (iii) at least one lightening and / or whitening ingredient chosen from vitamin B3 and its derivatives, the vitamin B3 derivatives comprising: - nicotinic acid esters such as tocopherol nicotinate, amides derived from niacinamide by substitution of the hydrogen groups of -CONH2, reaction products with carboxylic acids and amino acids, esters of nicotinyl alcohol and carboxylic acids such as acetic acid, salicylic acid, glycolic acid or palmitic acid; - 2-chloronicotinamide, 6-methylnicotinamide, 6-aminonicotinamide, N-methylnicotinamide, N,N-dimethylnicotinamide, N-(hydroxymethyl)nicotinamide, quinolinic acid imide, nicotinanilide, N-benzylnicotinamide, N-ethylnicotinamide, nifenazone, nicotinaldehyde, isonicotinic acid, methylisonicotinic acid, thionicotinamide, nialamide, 2-mercaptonicotinic acid, nicomol and niaprazine, methyl nicotinate and sodium nicotinate. - inorganic salts, such as chlorides, bromides, iodides or carbonates, and organic salts, such as salts obtained by reaction with carboxylic acids, such as acetate, salicylate, glycolate, lactate, malate, citrate, mandelate, tartrate,
2.
3. in which the composition is free of oil. Composition according to claim 1, in which the surfactant is chosen from esters of fatty acids and glycerol or polyglycerol, amino acid salts; betaines, and a mixture thereof. Composition according to any one of claims 1 to 2, in in which the surfactant is selected from esters of saturated or unsaturated C6-C30 fatty acids and glycerol or polyglycerol, lysinates, betaines, and a mixture thereof.
4. A composition according to any one of claims 1 to 3, wherein the surfactant is present in an amount ranging from 0.001% to 3% by weight, preferably from 0.003% to 2% by weight, more preferably from 0.005% to 1% by weight, relative to the total weight of the composition.
5. A composition according to claim 1, comprising in a hydrophilic phase, relative to the total weight of the composition: (i) from 8% to 20% by weight of a combination of butylene glycol, pentylene glycol and dipropylene glycol; (ii) from 0.005% to 1% by weight of at least one surfactant selected from sodium dilauramidoglutamide lysine, polyglyceryl-4 caprate, polyglyceryl-10 laurate, lauryl betaine and a mixture thereof; and (iii) from 1% to 8% by weight of vitamin B3, wherein the composition is oil-free.
6. Composition according to one of claims 1 to 5, in which the hydrophilic phase comprises water.
7. A non-therapeutic method for lightening and / or bleaching keratinous materials, comprising applying the composition according to any one of claims 1 to 6 to the keratinous materials.
